Description: AusCann is an Australian based company that was incorporated in September 2014 with theaim of producing and providing high quality, economical and clinically validated cannabismedicines to patients. It is bringing together leading expertise and operations across allaspects of the medical cannabis value chain, beginning with cultivation and production,through to manufacture and distribution of products and has built a strong team of expertsand partners with international connections. Partners includes TSX listed Canopy GrowthCorporations the largest producer of medicinal cannabis globally and DayaCann, the onlylicensed medicinal cannabis grower in Chile.
Home Page: auscann.com.au
1202 Hay Street
West Perth,
WA
6005
Australia
Phone:
61 8 6305 0705
Officers
| Name | Title |
|---|---|
| Mr. Christopher Mews A.C.I.S., B. Bus, C.P.A. | Chief Financial Officer |
| Ms. Rachel Jelleff Kerr | Company Secretary |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.3521 |
| Price-to-Sales TTM: | 1.2301 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |